J. Dahabre
Hospital Universitario Central de Asturias · 3 works · 204 citations · h-index 3
Top works
- Final results of a multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of MAGE-A3 immunotherapeutic as adjuvant therapy in stage IB/II non-small cell lung cancer (NSCLC)
- Is weekly paclitaxel superior to paclitaxel given every 3 weeks? Results of a phase II trial
- Multi-center, double-blind, randomized, placebo-controlled phase II study to assess the efficacy of recombinant MAGE-A3 vaccine as adjuvant therapy in stage IB/II MAGE-A3-positive, completely resected, non-small cell lung cancer (NSCLC)